Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SentiRect: SLNB in Rectal Cancer
NCT02445456Terminated
- Sponsor
- Oxford University Hospitals
- Start
- Dec 2016
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Open-label trial in rectal cancer (2 arms), sponsored by Oxford University Hospitals. Primary endpoints: Number of Participants Experiencing of Adverse or Hypersensitivity Reaction, Number of Operations Where Effects of Tracer Injection Can be Detected by Surgeon During Surgery and 1 more. Started Dec 2016; status: terminated.
02
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02445456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02445456.